For help on how to get the results you want, see our search tips.
291 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Categories
Human Remove Human filter
Authorisation status
Withdrawn Remove Withdrawn filter
-
List item
Human medicine European public assessment report (EPAR): PegIntron
peginterferon alfa-2b, Hepatitis C, Chronic
Date of authorisation: 24/05/2000, Revision: 36, Withdrawn, Last updated: 03/06/2021 -
List item
Human medicine European public assessment report (EPAR): Truberzi
eluxadoline, Irritable Bowel Syndrome; Diarrhea
Date of authorisation: 19/09/2016,
, Revision: 6, Withdrawn, Last updated: 25/02/2021
-
List item
Human medicine European public assessment report (EPAR): Prepandrix
A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 14/05/2008,
, Revision: 13, Withdrawn, Last updated: 23/02/2021
-
List item
Human medicine European public assessment report (EPAR): Enzepi
pancreas powder, Exocrine Pancreatic Insufficiency
Date of authorisation: 29/06/2016,, Revision: 1, Withdrawn, Last updated: 17/02/2021
-
List item
Human medicine European public assessment report (EPAR): Udenyca
pegfilgrastim, Neutropenia
Date of authorisation: 21/09/2018,, 
, Revision: 3, Withdrawn, Last updated: 15/02/2021
-
List item
Human medicine European public assessment report (EPAR): Halimatoz
adalimumab, Hidradenitis Suppurativa; Psoriasis; Arthritis, Juvenile Rheumatoid; Uveitis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic
Date of authorisation: 26/07/2018,, , Revision: 8, Withdrawn, Last updated: 29/01/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,
, Revision: 12, Withdrawn, Last updated: 25/01/2021
-
List item
Human medicine European public assessment report (EPAR): ViraferonPeg
peginterferon alfa-2b, Hepatitis C, Chronic
Date of authorisation: 28/05/2000, Revision: 36, Withdrawn, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Sebivo
telbivudine, Hepatitis B, Chronic
Date of authorisation: 24/04/2007, Revision: 20, Withdrawn, Last updated: 14/01/2021 -
List item
Human medicine European public assessment report (EPAR): Panretin
alitretinoin, Sarcoma, Kaposi
Date of authorisation: 11/10/2000, Revision: 17, Withdrawn, Last updated: 11/01/2021 -
List item
Human medicine European public assessment report (EPAR): Alpivab
Peramivir, Influenza, Human
Date of authorisation: 13/04/2018,, Revision: 2, Withdrawn, Last updated: 09/12/2020
-
List item
Human medicine European public assessment report (EPAR): Ribavirin Mylan (previously Ribavirin Three Rivers)
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 10/06/2010,, Revision: 10, Withdrawn, Last updated: 23/11/2020
-
List item
Human medicine European public assessment report (EPAR): Vepacel
Influenza virus (whole virion, inactivated), containing antigen of: A/Vietnam/1203/2004 (H5N1), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 17/02/2012, Revision: 9, Withdrawn, Last updated: 28/10/2020 -
List item
Human medicine European public assessment report (EPAR): Zerit
stavudine, HIV Infections
Date of authorisation: 08/05/1996, Revision: 31, Withdrawn, Last updated: 13/10/2020 -
List item
Human medicine European public assessment report (EPAR): Qtrilmet
metformin hydrochloride, Saxagliptin, dapagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2019, Revision: 2, Withdrawn, Last updated: 09/10/2020 -
List item
Human medicine European public assessment report (EPAR): Zurampic
lesinurad, Hyperuricemia
Date of authorisation: 18/02/2016,, Revision: 4, Withdrawn, Last updated: 31/07/2020
-
List item
Human medicine European public assessment report (EPAR): Picato
Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012,, Revision: 10, Withdrawn, Last updated: 31/07/2020
-
List item
Human medicine European public assessment report (EPAR): Kolbam
cholic acid, Metabolism, Inborn Errors
Date of authorisation: 20/11/2015,
, Revision: 14, Withdrawn, Last updated: 15/07/2020
-
List item
Human medicine European public assessment report (EPAR): Fertavid
follitropin beta, Infertility; Hypogonadism
Date of authorisation: 19/03/2009, Revision: 12, Withdrawn, Last updated: 23/06/2020 -
List item
Human medicine European public assessment report (EPAR): Helixate NexGen
octocog alfa, Hemophilia A
Date of authorisation: 04/08/2000, Revision: 31, Withdrawn, Last updated: 02/06/2020 -
List item
Human medicine European public assessment report (EPAR): Osseor
strontium ranelate, Osteoporosis, Postmenopausal
Date of authorisation: 20/09/2004, Revision: 19, Withdrawn, Last updated: 19/05/2020 -
List item
Human medicine European public assessment report (EPAR): Protelos
strontium ranelate, Osteoporosis, Postmenopausal
Date of authorisation: 20/09/2004, Revision: 19, Withdrawn, Last updated: 15/05/2020 -
List item
Human medicine European public assessment report (EPAR): Kromeya
adalimumab, Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Psoriasis; Arthritis, Psoriatic; Spondylitis, Ankylosing; Uveitis; Colitis, Ulcerative; Crohn Disease
Date of authorisation: 02/04/2019,, , Revision: 4, Withdrawn, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Xiapex
collagenase Clostridium histolyticum, Dupuytren Contracture
Date of authorisation: 28/02/2011, Revision: 20, Withdrawn, Last updated: 02/03/2020 -
List item
Human medicine European public assessment report (EPAR): Varuby
rolapitant, Vomiting; Nausea; Cancer
Date of authorisation: 19/04/2017,, Revision: 3, Withdrawn, Last updated: 02/03/2020